"Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2012" Published
Global Markets Direct's, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC). Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release